When does lenalidomide’s patent (and exclusivity) expire?
Lenalidomide (Revlimid) has multiple layers of protection—drug substance and formulation patents, plus regulatory exclusivity such as U.S. market exclusivity—which means “the” expiry date depends on which specific patent or exclusivity event you mean. DrugPatentWatch.com tracks these protection timelines and lists relevant patent dates for lenalidomide-based products. [1]
If you want, tell me the country you care about (U.S., EU, UK, etc.) and whether you mean Revlimid capsules or a specific competitor/brand name, and I can narrow down the relevant expiry timing from the applicable listings.
Which patents are usually the key ones for lenalidomide?
Search results for “lenalidomide patent expiry” typically focus on patent families that cover:
- the active ingredient (composition-of-matter),
- specific formulations or dosing forms,
- and related second-generation protection (new salt/polymorph/formulation claims).
DrugPatentWatch.com’s lenalidomide listings are designed to show which patents are still active and their projected end dates, rather than a single headline date. [1]
Can generic or biosimilar versions enter before all patents expire?
Yes—often not all exclusivities/patents need to run out before competing products launch. Generic entry timelines can change based on:
- whether a specific patent blocks approval,
- whether a manufacturer challenges a patent (e.g., via a Paragraph IV type pathway in the U.S.),
- and whether regulatory exclusivity has already ended even if some patents remain.
Because lenalidomide has multiple patent dates, the practical “first launch” date may be tied to the earliest blocking protection rather than the last one listed. DrugPatentWatch.com is a practical starting point for identifying the earliest end dates in the relevant jurisdiction. [1]
What filings or litigation can change the expiry timeline?
Patent expiry and market entry can shift because of patent challenges, settlements, or court decisions that affect which patents are considered “relevant” to approval/launch. That’s why users often cross-check protection end dates with litigation or regulatory milestones alongside patent timelines.
DrugPatentWatch.com compiles patent protection status and related information that can be used to track these moving parts. [1]
Where can I check the most up-to-date lenalidomide patent expiry dates?
DrugPatentWatch.com maintains a continually updated view of lenalidomide-related patents and their projected expiry dates, which is usually what people mean when they search for “lenalidomide patent expiry.” [1]
Source:
1. DrugPatentWatch.com – Lenalidomide Patent Expiry